Sexual lifestyle and clinical findings related to HTLV-III/LAV status in homosexual men. 1986

B A Evans, and S G Dawson, and K A McLean, and S A Teece, and P R Key, and R A Bond, and K D Macrae, and W J Jesson, and P P Mortimer

A study of 304 sexually active homosexual men, most of whom had multiple casual partners, showed that receptive anogenital intercourse, independent of anal bleeding, was the only risk factor for HTLV-III/LAV transmission. There was no evidence that HTLV-III/LAV infection, measured by seropositivity, was transmitted by oroanal or orogenital routes, or that insertive penile intercourse constituted a risk. The strongest predictor of seropositivity proved to be homosexual activity for more than five years, which may lead to enhanced susceptibility to infection. Sexual exposure to European men seemed to be even more hazardous than sexual exposure to men from the United States of America, and emphasised the epidemiological importance of the promiscuous homosexual abroad. Skin complaints were the most common presenting symptoms in men with antibody to HTLV-III/LAV. Extrainguinal lymphadenopathy was the commonest sign, which was present in just under half of those who were seropositive. More than one quarter of seropositive patients had had sexual intercourse with a woman in the five years before being tested.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D006678 HIV Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2. AIDS Virus,HTLV-III,Human Immunodeficiency Viruses,Human T-Cell Lymphotropic Virus Type III,Human T-Lymphotropic Virus Type III,LAV-HTLV-III,Lymphadenopathy-Associated Virus,Acquired Immune Deficiency Syndrome Virus,Acquired Immunodeficiency Syndrome Virus,Human Immunodeficiency Virus,Human T Cell Lymphotropic Virus Type III,Human T Lymphotropic Virus Type III,Human T-Cell Leukemia Virus Type III,Immunodeficiency Virus, Human,Immunodeficiency Viruses, Human,Virus, Human Immunodeficiency,Viruses, Human Immunodeficiency,AIDS Viruses,Human T Cell Leukemia Virus Type III,Lymphadenopathy Associated Virus,Lymphadenopathy-Associated Viruses,Virus, AIDS,Virus, Lymphadenopathy-Associated,Viruses, AIDS,Viruses, Lymphadenopathy-Associated
D006716 Homosexuality The sexual attraction or relationship between members of the same SEX. Homosexuality, Ego-Dystonic,Ego-Dystonic Homosexuality,Homosexuality, Ego Dystonic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D012306 Risk The probability that an event will occur. It encompasses a variety of measures of the probability of a generally unfavorable outcome. Relative Risk,Relative Risks,Risk, Relative,Risks,Risks, Relative

Related Publications

B A Evans, and S G Dawson, and K A McLean, and S A Teece, and P R Key, and R A Bond, and K D Macrae, and W J Jesson, and P P Mortimer
May 1986, American journal of public health,
B A Evans, and S G Dawson, and K A McLean, and S A Teece, and P R Key, and R A Bond, and K D Macrae, and W J Jesson, and P P Mortimer
March 1986, Ugeskrift for laeger,
B A Evans, and S G Dawson, and K A McLean, and S A Teece, and P R Key, and R A Bond, and K D Macrae, and W J Jesson, and P P Mortimer
November 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
B A Evans, and S G Dawson, and K A McLean, and S A Teece, and P R Key, and R A Bond, and K D Macrae, and W J Jesson, and P P Mortimer
May 1986, Lancet (London, England),
B A Evans, and S G Dawson, and K A McLean, and S A Teece, and P R Key, and R A Bond, and K D Macrae, and W J Jesson, and P P Mortimer
March 1986, The British journal of surgery,
B A Evans, and S G Dawson, and K A McLean, and S A Teece, and P R Key, and R A Bond, and K D Macrae, and W J Jesson, and P P Mortimer
November 1986, Nederlands tijdschrift voor geneeskunde,
B A Evans, and S G Dawson, and K A McLean, and S A Teece, and P R Key, and R A Bond, and K D Macrae, and W J Jesson, and P P Mortimer
November 1986, Nederlands tijdschrift voor geneeskunde,
B A Evans, and S G Dawson, and K A McLean, and S A Teece, and P R Key, and R A Bond, and K D Macrae, and W J Jesson, and P P Mortimer
March 1986, Ugeskrift for laeger,
B A Evans, and S G Dawson, and K A McLean, and S A Teece, and P R Key, and R A Bond, and K D Macrae, and W J Jesson, and P P Mortimer
August 1986, Lakartidningen,
B A Evans, and S G Dawson, and K A McLean, and S A Teece, and P R Key, and R A Bond, and K D Macrae, and W J Jesson, and P P Mortimer
May 1987, The American journal of medicine,
Copied contents to your clipboard!